Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal stem cells (MSCs), engineered bioprocess media, and bioprocess development services, announced a strategic partnership integrating RoosterBio's mesenchymal stem cell (MSC) and extracellular vesicle (EV) manufacturing platforms into Made Scientific's end-to-end CDMO offering which spans from initial process development through commercial-scale GMP manufacturing.
Under the agreement, Made Scientific will incorporate RoosterBio's off-the-shelf MSCs, proprietary MSC expansion and EV collection media, and bioprocess know-how across its GMP operations, establishing a commercially viable manufacturing platform for sponsors developing advanced therapies that utilize MSCs and MSC-derived EVs. The integrated platform is designed to accelerate development timelines, improve cost of goods, and support programs at every stage of clinical and commercial advancement.